BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15192330)

  • 1. LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals.
    Rintala-Maki ND; Sutherland LC
    Apoptosis; 2004 Jul; 9(4):475-84. PubMed ID: 15192330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis.
    Rintala-Maki ND; Abrasonis V; Burd M; Sutherland LC
    Cell Biochem Funct; 2004; 22(5):307-13. PubMed ID: 15338470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoprotein.
    Shu Y; Rintala-Maki ND; Wall VE; Wang K; Goard CA; Langdon CE; Sutherland LC
    Cell Biochem Funct; 2007; 25(6):643-53. PubMed ID: 16927403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBM5/LUCA-15--tumour suppression by control of apoptosis and the cell cycle?
    Mourtada-Maarabouni M; Williams GT
    ScientificWorldJournal; 2002 Jul; 2():1885-90. PubMed ID: 12920317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes.
    Mourtada-Maarabouni M; Keen J; Clark J; Cooper CS; Williams GT
    Exp Cell Res; 2006 Jun; 312(10):1745-52. PubMed ID: 16546166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5.
    Mourtada-Maarabouni M; Sutherland LC; Meredith JM; Williams GT
    Genes Cells; 2003 Feb; 8(2):109-19. PubMed ID: 12581154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells.
    Sutherland LC; Lerman M; Williams GT; Miller BA
    Oncogene; 2001 May; 20(21):2713-9. PubMed ID: 11420683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
    Rintala-Maki ND; Sutherland LC
    Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update.
    Maarabouni MM; Williams GT
    ScientificWorldJournal; 2006 Dec; 6():1705-12. PubMed ID: 17195868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis.
    Shao C; Zhao L; Wang K; Xu W; Zhang J; Yang B
    World J Surg Oncol; 2012 Aug; 10():160. PubMed ID: 22866867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways.
    Mourtada-Maarabouni M; Sutherland LC; Williams GT
    Apoptosis; 2002 Oct; 7(5):421-32. PubMed ID: 12207175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition.
    Bonnal S; Martínez C; Förch P; Bachi A; Wilm M; Valcárcel J
    Mol Cell; 2008 Oct; 32(1):81-95. PubMed ID: 18851835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells.
    Guo F; Sigua C; Tao J; Bali P; George P; Li Y; Wittmann S; Moscinski L; Atadja P; Bhalla K
    Cancer Res; 2004 Apr; 64(7):2580-9. PubMed ID: 15059915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor gene RBM5 delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverse apoptotic signaling pathways.
    Shao C; Yang B; Zhao L; Wang S; Zhang J; Wang K
    World J Surg Oncol; 2013 May; 11():123. PubMed ID: 23721095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells.
    Mariani SM; Matiba B; Armandola EA; Krammer PH
    J Cell Biol; 1997 Apr; 137(1):221-9. PubMed ID: 9105050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis.
    Zhao L; Li R; Shao C; Li P; Liu J; Wang K
    World J Surg Oncol; 2012 Nov; 10():247. PubMed ID: 23158838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression.
    Kim KM; Song JJ; An JY; Kwon YT; Lee YJ
    J Biol Chem; 2005 Dec; 280(49):41047-56. PubMed ID: 16199534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
    Rosato RR; Dai Y; Almenara JA; Maggio SC; Grant S
    Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.